Official guidance: FY2025 net sales $4.085B–$4.115B;gross profit $987M–$995M;adjusted EBITDA $247M–$253M;预计fully diluted share count约46M,因2028年到期convertible notes预计dilutive(CFO)
Mgmt quotes
| Metric | Value | Speaker/Context |
|---|---|---|
| Q3 net sales | $1.021B(vs $931.5M,+9.6%) | (CFO) |
| Q3 gross profit | $247.2M(vs $224.7M,+10%) | (CFO) |
| Q3 gross margin | 24.2%(+7 bps) | (CFO) |
| Q3 operating income | $38.9M(vs $31.9M) | (CFO) |
| Q3 adjusted EBITDA | $65.1M(vs $54.5M) | (CFO) |
| Q3 adjusted net income / EPS | $21.5M / $0.50(vs $15.4M / $0.36) | (CFO) |
| Q3 GAAP net income / EPS | $19.1M / $0.44(vs $14.1M / $0.34) | (CFO) |
| Liquidity | $224.6M(cash $65.1M + ABL $159.5M) | (CFO) |
| Net debt / leverage | 约 $575.2M / 约2.3x | (CFO) |
| FY2025 net sales guidance | $4.085B–$4.115B | (CFO) |
| FY2025 gross profit guidance | $987M–$995M | (CFO) |
| FY2025 adjusted EBITDA guidance | $247M–$253M | (CFO) |
| FY2025 fully diluted share count | 约46M | (CFO) |